TLR4 and infection: However, therapeutic targeting of either TLR2 or TLR4 from day two post-infection provided significant protection, suggesting that both TLR2 and TLR4 contribute to disease pathogenesis driven by damage-associated molecular patterns (DAMPs) [37].